Publications by authors named "Bruno Sepodes"

Claim this Profile
O
Oral Salvia officinalis phenolics abolish mortality and mitigate inflammation in acute TNBS murine colitis.
Rosa Direito, João Rocha, Inês Alves de Melo, Margarida Gonçalves, Maria Paula Duarte, Bruno Sepodes

Fitoterapia· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European Medicines Agency seeks stakeholders' views on its reflection paper on patient experience data.
Rosa Gonzalez-Quevedo, Juan Garcia Burgos, Marco Greco, Sabine Straus, Ulla Wändel Liminga, Bruno Sepodes

Br J Clin Pharmacol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European Medicines Agency approvals of new medicines in September and October 2025.
Bruno Sepodes, Juan Garcia Burgos, Steffen Thirstrup

Lancet Reg Health Eur· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Adding Immune Checkpoint Inhibitors to Standard Therapies in Non-Small Cell Lung Cancer: A Systematic Review of Efficacy Outcomes.
Ana Pinto Correia, Adriana Marques, Bruno Sepodes, Carla Torre, João Rocha

Crit Rev Oncol Hematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Data Included in Post-authorisation Measures: A Case Study of Approved Advanced Therapy Medicinal Products in the European Union between 2013 and 2024.
Diogo Almeida, Diana Mandslay, Peter G M Mol, Bruno Sepodes, Carla Torre

BioDrugs· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel approaches to the stratified management of knee osteoarthritis.
Nicholas R Fuggle, Roland Chapurlat, Andrea Laslop, Nasser Al-Daghri, Majed Alokail, Bruno Sepodes

Nat Rev Rheumatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of inflammatory pathways by cannabigerol in the collagen induced arthritis model in rats.
Monika Šteigerová, Michaela Sklenárová, Mykhaylo Bazyuk, Luděk Záveský, Petr Jelínek, Bruno Sepodes

Front Pharmacol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The European Medicines Agency evaluation of nemolizumab (Nemluvio) for the treatment of moderate-to-severe atopic dermatitis and prurigo nodularis.
Hendy Kristyanto, Sagrario Rey Torre, Anna Cunney, Kristina Dunder, Margareta Bego, Bruno Sepodes

Br J Dermatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The European Medicines Agency's review of Kaftrio (elexacaftor-tezacaftor-ivacaftor): extending its use to all people with CF aged 2 years and older who do not have two class I variants.
Catherine Drai, Hanneke J van der Woude, Anne J Lexmond, Tineke van den Hoorn, Peter G M Mol, Bruno Sepodes

Eur Respir J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing Patient Registries for Regulatory Decision Making - Key Learnings From an HMA/EMA Multistakeholder Workshop.
Kelly Plueschke, Carla Jonker, Hanna Kankanen, Thorsten Vetter, Bruno Sepodes

Clin Pharmacol Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thirty years of Europe's centralized procedure for approving medicines.
Emer Cooke, Bruno Sepodes

Nat Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Applying the EU Regulatory Framework to Determine the Benefit-Risk Profile of Psychedelics.
Kate Browne, Ewa Bałkowiec-Iskra, Andre Elferink, Marion Haberkamp, Sabine Straus, Bruno Sepodes

ACS Pharmacol Transl Sci· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stakeholders' Perspectives Toward the Use of Patient Registry Data for Decision-Making on Medicines: A Cross-Sectional Survey.
Fabian Windfuhr, Sieta T de Vries, Maria Melinder, Tanja Dahlqvist, Diogo Almeida, Bruno Sepodes

Drug Saf· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Evidence 2030.
Peter Arlett, Denise Umuhire, Patrice Verpillat, Paolo Foggi, Ulla Wändel Liminga, Bruno Sepodes

Clin Pharmacol Ther· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Review of studies evaluating the effectiveness of risk minimization measures for oncology medicinal products registered in the European Medicines Agency (HMA-EMA) catalogue: findings and lessons learned.
Jorge Monteiro, Diogo Almeida, João Paulo Fernandes, Bruno Sepodes, Carla Torre

Expert Opin Drug Saf· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Analysis of Post-Authorization Measures for Advanced Medicinal Products Authorized in the European Union and in the United States of America Between 2009 and 2023.
Diana Mandslay, Diogo Almeida, Adriana Marques, João Rocha, Frantisek Drafi, Bruno Sepodes

Clin Pharmacol Ther· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medicines for an aging population: The EMA perspective and policies.
Francesca Cerreta, Ewa Balkowiec Iskra, Amelia Cupelli, Bruno Sepodes, Elina Rönnemaa

J Am Geriatr Soc· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generating clinical evidence for treatment and prevention options for long COVID.
Stephanie Buchholz, Eugenia Di Meco, Ewa Z Bałkowiec-Iskra, Bruno Sepodes, Marco Cavaleri

Nat Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 pandemic and the consumption of self-care products for pediculosis capitis in Portugal: an interrupted time-series analysis.
Diogo Almeida, Antonio Teixeira Rodrigues, Jose Pedro Guerreiro, Ewa Bałkowiec-Iskra, Robert Vander Stichele, Bruno Sepodes

Parasitol Res· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends from two decades of orphan designations in paediatric rare neuromuscular diseases.
Dinah M Duarte, Maria Beatriz da Silva Lima, Bruno Sepodes

J Neurol Sci· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor mutational burden in colorectal cancer: Implications for treatment.
Adriana Marques, Patrícia Cavaco, Carla Torre, Bruno Sepodes, João Rocha

Crit Rev Oncol Hematol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leveraging patient experience data to guide medicines development, regulation, access decisions and clinical care in the EU.
Diogo Almeida, Denise Umuhire, Rosa Gonzalez-Quevedo, Ana António, Juan Garcia Burgos, Bruno Sepodes

Front Med (Lausanne)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plant-Derived Bioactive Compounds: Exploring Neuroprotective, Metabolic, and Hepatoprotective Effects for Health Promotion and Disease Prevention.
Rosa Direito, Sandra Maria Barbalho, Bruno Sepodes, Maria Eduardo Figueira

Pharmaceutics· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in orphan medicinal products approvals in the European Union between 2010-2022.
Luísa Bouwman, Bruno Sepodes, Hubert Leufkens, Carla Torre

Orphanet J Rare Dis· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inclusion of functional measures and frailty in the development and evaluation of medicines for older adults.
Michael Denkinger, Wilma Knol, Antonio Cherubini, Anita Simonds, Christos Lionis, Bruno Sepodes

Lancet Healthy Longev· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis